DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease - Financial Post

Exclusive licence of intelligence spot from the University of Kansas of a proprietary diagnostic instrumentality combining artificial quality and virtual world to assistance successful the diagnosis of neurological disorders for objective and telemedicine use

Enables distant neurological diagnosis connected a low-cost, portable virtual world instrumentality that tin visualize oculus movements successful videos and interface with the doc who is successful a antithetic determination than the patient, which whitethorn effect successful much close diagnoses, little clip spent connected making a close diagnosis for the physician, and little proscription costs for patients.

Initial absorption connected Parkinson’s illness with top-line results from a aviator survey successful mid-2023

TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” oregon the “Company”) (CSE: DMED), an artificial intelligence-driven integer diagnostics and therapeutics institution for encephalon health, is pleased to denote that it has entered into an exclusive worldwide licence statement with KU Center for Technology Commercialization, Inc., a non-profit corp of the University of Kansas, for the improvement and commercialization of intelligence spot of a caller virtual world and artificial quality neurodiagnostic strategy (“VR/AI Neuro”) for the evaluation, diagnosis and monitoring of neurodegenerative diseases, specified arsenic Parkinson’s disease.

Prototype of the VR/AI Neuro System

The VR/AI Neuro strategy complements and strengthens DiagnaMed’s projected full-spectrum integer diagnostics encephalon wellness solutions, which see BRAIN AGE™ and BrainTremor™, for intelligence wellness and neurological disorders. Early and close diagnosis is inactive hard for neurodegenerative conditions similar Parkinson’s disease. Evaluations tin beryllium time-consuming, patients indispensable often question to metropolitan areas oregon antithetic cities to spot experts, and misdiagnosis tin effect successful improper treatment. Only a fistful of assistive oregon distant methods beryllium to assistance physicians measure patients with suspected neurological diseases conveniently and consistently. The VR/AI Neuro strategy aims to alteration objective and distant neurological diagnosis connected a low-cost, portable virtual world instrumentality that tin visualize oculus movements successful videos and interface with the doc who is successful a antithetic determination than the patient, which whitethorn effect successful much close diagnoses, little clip spent connected making a close diagnosis for the physician, and little proscription costs for patients.

The VR/AI Neuro strategy has been successful probe and co-development for immoderate clip by Kansas University Medical Center, Osaka University and Augusta University. It is designed to enactment the valuation and diagnosis of neurodegenerative illness and trial its usage successful a objective setting. Using a commercially disposable VR show with an infrared camera integrated into the lens, researchers person constructed a 3D virtual situation designed to emulate communal tasks utilized to measure patients, specified arsenic fixating connected a point, conducting creaseless pursuit of an object, oregon executing saccades. These virtual tasks are designed to elicit oculus movements commonly associated with neurodegenerative diseases, specified arsenic abnormal saccades, quadrate question jerks, and ocular tremors. Researchers past conducted experiments with 9 patients diagnosed with Parkinson’s illness and 7 steadfast controls to trial the VR/AI Neuro system’s imaginable to emulate tasks for objective diagnosis. Researchers past applied eye-tracking algorithms and representation enhancement to the oculus recordings taken during the experimentation and conducted a abbreviated follow-up survey with 2 physicians for evaluation. Results showed that the VR/AI Neuro strategy interface could elicit 5 communal types of movements usable for evaluation, physicians could corroborate 3 retired of 4 abnormalities, and visualizations were rated arsenic perchance utile for diagnosis. [1] 

With the occurrence of the proof-of-concept study, the adjacent improvement signifier is to re-implement the tests created successful the archetypal probe utilizing the updated VR/AI Neuro strategy and integrate it into a objective mounting with Parkinson’s illness patients with top-line results from the aviator survey by mid-2023.

“We are excited to beforehand the improvement of a caller virtual world and artificial quality neurodiagnostic strategy that volition purpose to alteration the mode neurodegenerative diseases are diagnosed and managed,” said Fabio Chianelli, Chairman of the Board of DiagnaMed. “We are focused connected processing and commercializing next-generation integer diagnostic tools for encephalon wellness successful intelligence wellness and neurological disorders. The VR/AI Neuro strategy complements our merchandise improvement programs, including BRAIN AGE™ and BrainTremor™, to guarantee a afloat suite of valuation solutions for healthcare providers to negociate their patient’s conditions effectively.”

Under the presumption of the Agreement, DiagnaMed gained exclusive worldwide improvement and commercialized rights to an intelligence spot portfolio from KU Center for Technology Commercialization, Inc.

About DiagnaMed Holdings Corp.

DiagnaMed Holdings Corp. (CSE: DMED) is an artificial intelligence-driven integer diagnostics and therapeutics institution focusing connected improving encephalon wellness for intelligence wellness and neurodegenerative disorders. The Company is processing BRAIN AGE™, an electroencephalogram-based (EEG) artificial quality solution to observe an individual’s encephalon property for objective and location use, and BrainTremor™, a wearable instrumentality to observe tremors for Parkinson’s illness and indispensable tremors. Learn much astatine DiagnaMed.com.

For much accusation astir DiagnaMed, delight contact:

Neither the Canadian Securities Exchange nor its Regulation Services Provider person reviewed oregon judge work for the adequacy oregon accuracy of this release.

Cautionary Statement

Certain statements successful this quality merchandise are forward-looking statements, including with respect to aboriginal plans, and different matters. Forward-looking statements dwell of statements that are not purely historical, including immoderate statements regarding beliefs, plans, expectations oregon intentions regarding the future. Such accusation tin mostly beryllium identified by the usage of forwarding-looking wording specified arsenic “may”, “expect”, “estimate”, “anticipate”, “intend”, “believe” and “continue” oregon the antagonistic thereof oregon akin variations. The scholar is cautioned that assumptions utilized successful the mentation of immoderate forward-looking accusation whitethorn beryllium to beryllium incorrect. Events oregon circumstances whitethorn origin existent results to disagree materially from those predicted, arsenic a effect of galore known and chartless risks, uncertainties, and different factors, galore of which are beyond the power of the Company, including but not constricted to, business, economical and superior marketplace conditions, the quality to negociate operating expenses, and dependence connected cardinal personnel. Such statements and accusation are based connected galore assumptions regarding contiguous and aboriginal concern strategies and the situation successful which the Company volition run successful the future, anticipated costs, and the quality to execute goals. Factors that could origin the existent results to disagree materially from those successful forward-looking statements include, the continued availability of superior and financing, litigation, nonaccomplishment of counterparties to execute their contractual obligations, nonaccomplishment of cardinal employees and consultants, and wide economic, marketplace oregon concern conditions. Factors that could origin existent results to disagree materially from those anticipated successful these forward-looking statements are described nether the caption “Risk Factors” successful DiagnaMed’s last prospectus dated October 28, 2022, which is disposable connected the Company’s illustration astatine www.sedar.com. Forward-looking statements contained successful this quality merchandise are expressly qualified by this cautionary statement. The scholar is cautioned not to spot undue reliance connected immoderate forward-looking information. The forward-looking statements contained successful this quality merchandise are made arsenic of the day of this quality release. Except arsenic required by law, the Company disclaims immoderate volition and assumes nary work to update oregon revise immoderate forward-looking statements, whether arsenic a effect of caller information, aboriginal events oregon otherwise.

This quality merchandise does not represent an connection to merchantability oregon the solicitation of an connection to buy, and shall not represent an offer, solicitation oregon merchantability successful immoderate state, province, territory oregon jurisdiction successful which specified offer, solicitation oregon merchantability would beryllium unlawful anterior to registration oregon qualification nether the securities laws of immoderate specified state, province, territory oregon jurisdiction.

Source:

A photograph accompanying this announcement is disposable astatine https://www.globenewswire.com/NewsRoom/AttachmentNg/737715b3-ff6e-4e46-b350-7548d60df582